Very few ARV medications (notably ZDV, nevirapine, lamivudine, abacavir, and raltegravir) are considered safe and effective for infants < 14 days postnatal age, and fewer still (only zidovudine, lamivudine, nevirapine, and, for late preterm infants, raltegravir) have dosing data available for preterm infants.